BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gale N, McEwan M, Camacho OM, Hardie G, Proctor CJ, Murphy J. Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Intern Emerg Med 2021. [PMID: 34196886 DOI: 10.1007/s11739-021-02798-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Azzopardi D, Haswell LE, Frosina J, McEwan M, Gale N, Thissen J, Meichanetzidis F, Hardie G. Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers. Biomarkers 2023;28:118-29. [PMID: 36484137 DOI: 10.1080/1354750X.2022.2148747] [Reference Citation Analysis]
2 Begić E, Aziri B, Omeragić E, Medjedović E, Iglica A, Stanetić B, Kovačević-Preradović T, Živanović Ž, Begić A, Janković S, Mlačo N, Mladenović Z, Badnjević A. Heat-not-burn tobacco products and cardiovascular risk reduction: A systematic review of randomized controlled trials. Technol Health Care 2023. [PMID: 36641697 DOI: 10.3233/THC-220677] [Reference Citation Analysis]
3 Round EK, Marano K. Biomarkers of Tobacco Use: Relevance to Tobacco Harm Reduction. Biomarkers in Toxicology 2023. [DOI: 10.1007/978-3-031-07392-2_51] [Reference Citation Analysis]
4 Braznell S, Van Den Akker A, Metcalfe C, Taylor GMJ, Hartmann-boyce J. Critical appraisal of interventional clinical trials assessing heated tobacco products: a systematic review. Tob Control 2022. [DOI: 10.1136/tc-2022-057522] [Reference Citation Analysis]
5 Morjaria JB, Campagna D, Caci G, O'Leary R, Polosa R. Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence. Expert Rev Respir Med 2022;16:1213-26. [PMID: 36638185 DOI: 10.1080/17476348.2023.2167716] [Reference Citation Analysis]
6 Azzopardi D, Haswell LE, Frosina J, McEwan M, Gale N, Thissen J, Meichanetzidis F, Hardie G. Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study. JMIR Res Protoc 2022;11:e39785. [PMID: 36201395 DOI: 10.2196/39785] [Reference Citation Analysis]
7 Caponnetto P, Campagna D, Maglia M, Benfatto F, Emma R, Caruso M, Caci G, Busà B, Pennisi A, Ceracchi M, Migliore M, Signorelli M. A randomized controlled trial Comparing Effectiveness, tolerability, and Acceptability of Heated Tobacco ProductS vs. refillable Electronic cigarettes For cIgaREttes substitution: CEASEFIRE study. (Preprint).. [DOI: 10.2196/preprints.42628] [Reference Citation Analysis]
8 Caponnetto P, Campagna D, Maglia M, Benfatto F, Emma R, Caruso M, Caci G, Busà B, Pennisi A, Ceracchi M, Migliore M, Signorelli M. Comparing Effectiveness, tolerability, and Acceptability of Heated Tobacco ProductS vs. refillable Electronic cigarettes For cIgaREttes substitution: CEASEFIRE randomized controlled trial (Preprint). JMIR Public Health and Surveillance 2022. [DOI: 10.2196/42628] [Reference Citation Analysis]
9 Hardie G, Gale N, McEwan M, Oscar SM, Ziviani L, Proctor CJ, Murphy J. An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy. Sci Rep 2022;12:14701. [PMID: 36038580 DOI: 10.1038/s41598-022-19167-8] [Reference Citation Analysis]
10 Gale N, McEwan M, Hardie G, Proctor CJ, Murphy J. Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking. Intern Emerg Med 2022. [PMID: 36036342 DOI: 10.1007/s11739-022-03062-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Goodall S, Gale N, Thorne D, Hadley S, Prasad K, Gilmour I, Miazzi F, Proctor C. Evaluation of behavioural, chemical, toxicological and clinical studies of a tobacco heated product glo™ and the potential for bridging from a foundational dataset to new product iterations. Toxicol Rep 2022;9:1426-42. [PMID: 36561950 DOI: 10.1016/j.toxrep.2022.06.014] [Reference Citation Analysis]
12 Azzopardi D, Ebajemito J, McEwan M, Camacho OM, Thissen J, Hardie G, Voisine R, Mullard G, Cohen Z, Murphy J. A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products. Sci Rep 2022;12:6949. [PMID: 35484309 DOI: 10.1038/s41598-022-10544-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Malt L, Thompson K, Mason E, Walele T, Nahde T, O'connell G. The product science of electrically heated tobacco products: a narrative review of the scientific literature. F1000Res 2022;11:121. [DOI: 10.12688/f1000research.74718.1] [Reference Citation Analysis]
14 Tattan-Birch H, Hartmann-Boyce J, Kock L, Simonavicius E, Brose L, Jackson S, Shahab L, Brown J. Heated tobacco products for smoking cessation and reducing smoking prevalence. Cochrane Database Syst Rev 2022;1:CD013790. [PMID: 34988969 DOI: 10.1002/14651858.CD013790.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Round EK, Marano K. Biomarkers of Tobacco Use: Relevance to Tobacco Harm Reduction. Biomarkers in Toxicology 2022. [DOI: 10.1007/978-3-030-87225-0_51-1] [Reference Citation Analysis]
16 Polosa R. Examining the evidence for the health impact of combustion-free products: progress and prospects for tobacco harm reversal and reduction. Intern Emerg Med 2021;16:2043-6. [PMID: 34524625 DOI: 10.1007/s11739-021-02837-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]